Delivery Order SPE2DP20D0002-SPE2DP24F8000

Award Date 9/18/24
Potential Completion Date 9/24/24
Potential Value $476K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DP20D0002
    Indefinite Delivery Contract
  • SPE2DP20D0002-SPE2DP24F8000
    Delivery Order

This is a $476,414.19 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons, and Indian Health Service. The contract does not have a set-aside designation, as Teva competes as a large business in unrestricted solicitations. Teva Pharmaceuticals USA, Inc. holds several significant Indefinite Delivery Contracts (IDCs) with federal agencies, demonstrating its crucial role in maintaining pharmaceutical supplies for federal healthcare programs, including the supply of glatiramer acetate injections for multiple sclerosis treatment, Albuterol HFA inhalers for respiratory care, and Levalbuterol HCL solution.

Generated 12/18/24, 9:02 AM